Familial mediterranean fever treated with anakinra: A case report;Fiebre mediterránea familiar en tratamiento con anakinra: a propósito de un caso

Reumatologia Clinica

Volumn 13, Issue 2, 2017, Pages 120-121

  Espíldora Hernández, Javier ^a   Abarca Costalago, Manuel ^a  

^a HOSPITAL UNIVERSITARIO VIRGEN DE LA VICTORIA   (Spain)

Author keywords

[No Author keywords available]

Indexed keywords

ANAKINRA; ANTIRHEUMATIC AGENT; COLCHICINE; INTERLEUKIN 1 RECEPTOR BLOCKING AGENT;

CASE REPORT; FAMILIAL MEDITERRANEAN FEVER; HUMAN; LETTER; ADULT; COMBINATION DRUG THERAPY; MALE;

ADULT; ANTIRHEUMATIC AGENTS; COLCHICINE; DRUG THERAPY, COMBINATION; FAMILIAL MEDITERRANEAN FEVER; HUMANS; INTERLEUKIN 1 RECEPTOR ANTAGONIST PROTEIN; MALE;

EID: 85003422198     PISSN: 1699258X     EISSN: 18851398     Source Type: Journal    
DOI: 10.1016/j.reuma.2016.06.001     Document Type: Letter

References (10)

1. 1 Soriano, A., Verecchia, E., Afeltra, A., Landolfi, R., Manna, R., IL-1β biological treatment of familial mediterranean fever. Clin Rev Allergy Immunol. 45 (2013), 117–130.
2. 2 Avi Livneh MD. Colchicine failure in familial mediterranean fever and potential alternatives: embarking on the anakinra trial [consultado 16 Dic 2015]. Disponible en: https://www.ima.org.il/FilesUpload/IMAJ/0/79/39873.pdf.
3. 3 Lidar, M., Yonath, H., Shechter, N., Sikron, F., Sadetzki, S., langevitz, P., et al. Incomplete response to colchicine in M694 V homozygote FMF patients. Autoimmun Rev. 12 (2012), 72–76.
4. 4 Grattagliano, I., Bonfrate, L., Ruggiero, V., Scaccianoce, G., Palasciano, G., Portincasa, P., Novel therapeutics for the treatment of familial Mediterranean fever: From colchicine to biologics. Clin Pharmacol Ther. 95 (2014), 89–97.
5. 5 Stankovic Stojanovic, K., Delmas, Y., Urena Torres, P., Peltier, J., Pelle, G., Jeru, I., et al. Dramatic beneficial effect of interleukin-1 inhibitor treatment in patients with familial Mediterranean fever complicated with amyloidosis and renal failure. Nephrol Dial Transplant. 27 (2012), 1898–1901.
6. 6 Stoll, M.L., Gotte, A.C., Biological therapies for the treatment of juvenile idiopathic arthritis: Lessons from the adult and pediatric experiences. Biol Targets Ther. 2 (2008), 229–252.
7. 7 Eroglu, F.K., Beşbaş, N., Topaloglu, R., Ozen, S., Treatment of colchicine-resistant Familial Mediterranean fever in children and adolescents. Rheumatol Int. 35 (2015), 1733–1737.
8. 8 Ferris Villanueva, E., García Coronel, M., Guerrero Bautista, R., Uso de anakinra en un caso de fiebre mediterránea familiar. Farm Hosp. 38 (2014), 446–448.
9. 9 Javadi Parvaneh V, Shiari R. Treatment of colchicine-resistant familial Mediterranean fever with anakinra. Arch Pediatr Infect Dis [Internet] [accedido 20 Jul 2015; consultado 23 Mayo 2016];3(3). Disponible en: http://www.pedinfect.com/?page=article&article_id=21664.
10. 10 Van der Hilst, J., Moutschen, M., Messiaen, P., Lauwerys, B., Vanderschueren, S., Efficacy of anti-IL-1 treatment in familial Mediterranean fever: A systematic review of the literature. Biol Targets Ther. 10 (2016), 75–80.